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Background
Charcot-Marie-Tooth disease (CMT) causes peripheral
nerve demyelination, progressive foot weakness, cavus
deformity, difficulty walking and sensory loss. There is a
need for accurate, sensitive and disease-relevant mea-
sures of young children through to adolescents with
CMT to enable accurate assessment of baseline perfor-
mance, monitor disease severity longitudinally, and
determine responses to existing and novel foot and
ankle interventions. Our objective was to develop a
multidimensional scale to measure disease severity of
children with CMT, known as the CMT Pediatric Scale
(CMTPedS).
Methods
The CMTPedS has undergone a thorough development
process: (1) definition of the construct; (2) generation of
the item pool; (3) choice of scoring format; (4) peer-
review (face validity); (5) pilot testing; (6) standardised
training; (7) inter-rater reliability of four international
centres assessing eight children with CMT; (8) multicen-
ter implementation.
Results
Findings of the development process: (1) the CMTPedS
is a composite scale with broad application to measure
disease severity of childhood CMT with eight domains
capturing symptoms, foot/ankle involvement, lower limb
sensation, hand dexterity/strength, balance, motor func-
tion; (2) a large pool of items generated from the litera-
ture were reduced based on disease-specificity,
functional/patient-relevance, reliability/validity, pub-
lished norms, test duration and ease of interpretation;
(3) items collapsed to 5-point Likert scales using
z-scores based on age/gender norms; (4) quality, appro-
priateness and suitability of items peer-reviewed by 23
expert clinicians/researchers/patient representatives at
the 168th European Neuromuscular Centre Interna-
tional Workshop; (5) pilot-tested on four children with
CMT to check for administration problems, item
instructions, order and duration; (6) clinicians from
USA, UK, Italy and Australia trained through work-
shops, online manual and video resources; (7) all items
exhibited good to excellent inter-rater reliability
(ICC2,40.78-0.99) (8) a multicenter natural history study
of children with all types of CMT aged 3-17 years is
underway, with 90 children recruited to date.
Conclusions
Application and psychometric validation of the
CMTPedS continues. We plan to apply the final
CMTPedS as the primary outcome in clinical trials of
podiatric, pharmacological and surgical interventions.
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